Professional Documents
Culture Documents
The Supply Chain of The Future
The Supply Chain of The Future
A LogiPharma Report
logipharmaeu.wbresearch.com
01 The Supply Chain of the Future
A LogiPharma Report
“
LogiPharma is without doubt the number one
industry supply chain conference in Europe.
The combination of high-quality presentations
and opportunities to network with peers from
other companies makes it unique.
“
Arie Moruanx, Global Surgery Planning Excellence Director
Contents
Introduction 02
Getting ahead of the game in supply chain 03
United Cargo 04
OM Movianto 05
Part 1: Challenges and Opportunities 06
Part 2: Investments and Actions 12
Part 3: Supply Chain Visibility 18
About E2open 22
About OM Movianto 22
About United Cargo TempControl 22
About WBR Digital 22
The Supply Chain of the Future
A LogiPharma Report 02
Introduction
Now, perhaps more than ever, Supply Chain is at the very heart of success for the
world’s most important pharmaceutical companies.
As a result the hunt is on for innovative ways to transform the supply chain to
enable on-time delivery in the most cost-efficient manner possible. Although this
may seem a modest proposal, it presents significant challenges.
We approached 100 senior decision makers in the industry, with job titles like Vice
President of Supply Chain Management, Global Head of Supply Chain, Director
of SCM & Procurement, as well as others of a similar standing to compile this
research report.
The results of our research have been aggregated, anonymised and are presented
here to give you an insight into how your peers are responding to these challenges.
Additional contributors
The pharmaceutical industry recognizing that this new setup When companies deploy such
has been one of the best- requires advanced solutions. approaches, the benefits are
performing industries of the past substantial:
decades with pharma companies Leading pharma companies are,
excelling at many disciplines to a large extent, leveraging the l Up-to-date, supply chain
– research and development, experience of other industries visibility – “one version of the
manufacturing, sales and while taking into account the truth” shared across all
marketing – while maintaining specifics of the pharma industry. partners of the extended
the highest safety and quality The new approach is to run such supply chain
standards. Today the pharma a multi-enterprise supply chain
l Full quality control of CMOs
industry is going through major through a supply chain operating
changes: the rise of generics network such as that provided l as required for traceability
and the resulting competitive by E2open. The foundation is a and serialization
intensity, an ever-growing business network that connects
product portfolio, demanding all partners in real-time for l Higher on-shelf availability,
customers and retailers, and true end-to-end visibility and generally with lower inventories
new regulatory requirements. collaboration. Such a network
also allows companies to have l Through smarter channel
The supply chain function has a deep visibility into the operations allocations, better margins
key role to play to help address of their contract manufacturers and also ultimately higher
the new challenges. In particular, to capture quality as well as batch market share
increasingly global and information – so companies can
outsourced supply chains bring trace quality issues even if they The early adopters in the pharma
additional complexity and many outsource production. Once this industry are already capturing
pharma companies struggle platform is in place, dedicated these benefits, putting themselves
to run increasingly “virtual” supply chain solutions provide the ahead of their peers.
supply chains. Today’s virtual required insights and decision-
supply chains require a much support to supply chain teams.
higher degree of coordination
and alignment across all supply A key area that has emerged
chain partners and activities. is the importance of better
Achieving better supply chain managing the downstream part
visibility and collaboration across of the supply chain, where new
the entire supply chain is not technologies like demand sensing
something ERP systems or – first adopted by consumer goods
traditional business applications companies – can dramatically
can solve because they only focus help pharmaceutical companies
on what’s happening inside a increase their on-shelf availability,
company’s four walls. As a result, in hospitals or at retail locations.
pharmaceutical companies are
SM
right time,
friendly
right temp
©2017 United Airlines, Inc. All rights reserved.
unitedcargo.com
05 The Supply Chain of the Future
A LogiPharma Report
16%
Latin/South America
15%
16 %
Russia & CIS
Rest of Asia
18%
Eastern Europe
3 % 25%
Asia Pacific
Middle East &
North Africa
7%
Africa
The Supply Chain of the Future
A LogiPharma Report 08
1 2 3 4 5
09 The Supply Chain of the Future
A LogiPharma Report
understanding of the
trade-offs between
26%
different models Fully operational – we have
been distributing by direct-
No plans to implement
25%
Supply chain will have a
much greater influence
on market access
42%
Supply chain will have a much
more significant impact on the
bottom line of the company
Part Two:
Investments and Actions
13 The Supply Chain of the Future
A LogiPharma Report
64%
Yes absolutely – it’s important
to work with other pharma
companies to develop a more
effective supply chain
The Supply Chain of the Future
A LogiPharma Report 14
40%
Consolidating or finding
new transportation
service providers
27%
Reassessing and changing strategy
for freight – sea vs. air. vs. truck vs. rail
15 The Supply Chain of the Future
A LogiPharma Report
39%
Yes – mobile apps & devices,
data analytics are all extremely
important to the supply chain
37%
Yes, somewhat – data analytics and
an information-enriched end-to-end
supply chain is important
The Supply Chain of the Future
A LogiPharma Report 16
4.19
Big Data
4.29
Blockchain Technology
4.54
Industry 4.0 and the Internet of Things
17 The Supply Chain of the Future
A LogiPharma Report
One complication is
how to get quality
and traceability data
26%
Very prepared – we have
all of our processes and
when part of the technologies in place
manufacturing is
outsourced. This is
why companies have
turned to E2open
to gain visibility into
their CMO.
“
Patrick Lemoine
Vice President, Product Marketing, E2open
59%
Somewhat prepared, but we are still
developing our processes and technologies
Part Three:
Supply Chain Visibility
19 The Supply Chain of the Future
A LogiPharma Report
49%
Very Good
29%
Good
8%
Fair
0%
Poor
The Supply Chain of the Future
A LogiPharma Report 20
CMOs / Packaging
DCs
Distributors/customers
0 1 2 3 4
21 The Supply Chain of the Future
A LogiPharma Report
1 2 3 4 5
The Supply Chain of the Future
A LogiPharma Report 22
About: E2open
Founded in 2000, E2open provides the largest and most comprehensive Supply Chain Operating Network,
including a broad suite of collaborative supply chain solutions. Leading global enterprises, including pharma and
biotech companies, rely on E2open to provide greater end-to-end visibility, more accurate data and insights, and
real-time business process orchestration across complex, multi-enterprise trading partner networks.
About: OM Movianto
As part of US-based Owens & Minor Inc., we are a healthcare dedicated pan-European network operating in
over 15 European countries with a diverse product and service offering.
OUR Vision is to connect the world’s leading life-science companies to the point of care to enable better
patient outcomes.
OUR Mission is to remain fully focused on delivering healthcare services and solutions. We seek to
understand the volume and technical demands of our clients product portfolio to ensure we enable flexible
and customised patient centric solutions, through a pan European platform that offers consistency,
reliability and resilience of service underpinned by a total focus on our quality management systems.
We are a team of marketers, researchers and writers with a passion for content with a creative twist. From
research-based whitepapers focused on your priorities, to benchmarking reports, infographics and webinars,
we can help you to inform and educate your readers and reach your marketing goals at the same time.
Contact: Chamatkar Sandhu, Digital Sales Director, +44 (0)20 7368 9383, chamatkar.sandhu@wbr.co.uk.